Boston Scientific to Acquire Nalu Medical

October 17, 2025

Utrecht (the Netherlands) & Boston, MA (United States)

We are pleased to announce the strategic exit of our portfolio company Nalu Medical. Boston Scientific, a global leader in medical technology, has agreed to acquire Gilde Healthcare portfolio company Nalu Medical at a $600m valuation.

Nalu Medical markets a miniaturized implantable neurostimulation device to treat patients with chronic neuropathic pain.
Boston Scientific expects to complete the transaction in the first half of 2026, subject to customary closing conditions.

Gilde Healthcare co led the $104m financing round in 2022 and Geoff Pardo serves on the Board of Directors.

Press Release

More news

Okami Medical Announces $45 Million Financing and New CEO Appointment to Drive Next Phase of Growth

Okami Medical, a medical technology company pioneering novel vascular embolization solutions, today announced the successful close of an oversubscribed $45M financing led by new investor Gilde Healthcare with participation from existing investors including Vensana Capital and...

November 20, 2025

Gilde Healthcare acquires MEG, a group of specialized providers of medical aids, from Harald Quandt Industriebeteiligungen (“HQIB”)

Gilde Healthcare’s private equity fund today announced the acquisition of MEG Medical Equipment GmbH (“MEG”), a provider of high-quality medical aids for treatment and prevention of decubitus and other skin damages resulting from extended immobility,...

November 14, 2025